Related Experiment Video
Updated: May 16, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Intravenous Fluid Therapy Choice in Trauma Patients in the Intensive Care Unit: A Scoping Review
Aaron McKee1, Nancy Moriber2, Joni Tornwall3
1Aaron McKee is a Doctor of Nursing Practice student specializing in adult/gerontology acute care, The Ohio State University College of Nursing, Columbus, Ohio.
For trauma patients, fluid choice matters less, except for those with traumatic brain injury (TBI). Normal saline is preferred for TBI patients, while other fluids are generally interchangeable for trauma resuscitation.
Area of Science:
- Critical Care Medicine
- Trauma Surgery
- Fluid Resuscitation
Background:
- Intravenous fluid resuscitation in critically ill patients is debated.
- Limited evidence exists for fluid choices in trauma patients.
Purpose of the Study:
- To review current recommendations for intravenous fluid resuscitation in trauma patients.
- To assess the impact of fluid choices on patient outcomes.
Main Methods:
- Scoping review utilizing the Joanna Briggs Institute framework.
- Appraisal of 10 articles on crystalloid and colloid solutions.
Main Results:
- No significant difference in major adverse outcomes (mortality, AKI, LOS) with crystalloid types, except for TBI patients.
- Normal saline showed benefit in traumatic brain injury (TBI) patients.
- Albumin and hypertonic saline were generally safe adjuncts, except in TBI.
Conclusions:
- Balanced crystalloids and normal saline are interchangeable for trauma patients, excluding TBI.
- Albumin's use as first-line resuscitation is questionable due to cost and lack of demonstrated benefit.
- Hypertonic saline may benefit patients with delayed abdominal closure.
More Related Videos
09:17Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016